Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
Monitoring for side effects is essential, particularly during the initial weeks of treatment or when doses are adjusted
Fixed-ratio combination products containing both insulin and a GLP-1 receptor agonist are also available, including insulin glargine/lixisenatide (Soliqua) and insulin degludec/liraglutide (Xultophy)
A refreshing face wash that deeply cleanses, removes dark patches, and preps skin for better product absorption
While the results can be long-lasting, maintaining a healthy lifestyle through diet and exercise is essential to maximise and sustain the benefits of the treatment
GLP-1 increases endogenous insulin secretion, which supports the use of DPP-4 inhibitors early in the disease process
US$ 22.78
US$ 22.01
US$ 21.68
US$ 25.71
